We spotlight five grantees whose work exemplifies our approach to hits-based giving in scientific research. These examples illustrate different aspects of our science funding strategy and represent some of the project types we aim to support.
Editor’s note: This article was published under our former name, Open Philanthropy. Some content may be outdated. You can see our latest writing here. As we enter the holiday giving season, we’re continuing our tradition of sharing a list of giving opportunities suggested by Open Philanthropy program staff. Notes on...
This piece compiles some of the most notable writings on AI by current and former staff over the last decade. They are not intended to represent our “institutional view” on AI. No such view exists — our program staff, as well as our grantees, often disagree with each other.
In October, our longtime grantee David Baker won the Nobel Prize in Chemistry for groundbreaking work in protein design. We wanted to take the opportunity to highlight his work and some of its practical applications, such as enabling better vaccines.
Rossa O'Keeffe-O'Donovan, Rafael Latham-Proença and Oliver Kim
/
Announcements
/
October 16, 2024
Editor’s note: This article was published under our former name, Open Philanthropy. Some content may be outdated. You can see our latest writing here. This is a high-level summary of our approach to launching a program focused on economic growth in low- and middle-income countries (LMICs) and not a medium...
This post announced the launch of LEAF. It explains why lead exposure is such a devastating issue, what the fund aims to achieve, and where we committed our first $20+ million in grants.
The Global Aid Policy team estimates that in Western nations like the U.K., for every $1,000 spent on overseas development assistance, aid advocacy funders spend around $2.60 attempting to support and inform its allocation. Meanwhile, in Japan, advocacy spending is a mere $0.25 for the same amount. The following case study highlights one grantee helping to drive this work forward.